www.esmo.org Open in urlscan Pro
3.74.48.128  Public Scan

Form analysis
2 forms found in the DOM

GET /content/search

<form class="navbar-search" method="get" action="/content/search">
  <span class="searchbox-toggle"></span>
  <input class="search-query search-autocomplete" autocomplete="off" type="search" name="searchText" id="site-wide-search-field" placeholder="Search for Abstracts, Guidelines, Meetings" aria-label="Search">
  <input type="checkbox" name="search[sections][]" value="1074" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1065" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1096" data-parent-id="1065" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1093" data-parent-id="1065" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1133" data-parent-id="1065" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1099" data-parent-id="1065" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1136" data-parent-id="1065" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1077" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1310" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1071" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1053" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1062" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1100" data-parent-id="1062" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1087" data-parent-id="1062" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1106" data-parent-id="1062" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1090" data-parent-id="1062" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1059" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1056" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1047" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1080" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1109" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1050" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1112" data-parent-id="720" class="tag-input" hidden="hidden">
  <div class="clear-toggle"><span class="clear-icon"></span></div>
  <button type="submit" class="search-submit btn btn-primary" title="Search"> Search </button>
  <div class="autocomplete-suggestions" style="position: absolute; display: none; width: 100%; max-height: 300px; z-index: 1;"></div>
</form>

GET /content/search

<form class="navbar-search" method="get" action="/content/search">
  <span class="searchbox-toggle"></span>
  <input class="search-query search-autocomplete" autocomplete="off" type="search" name="searchText" id="site-wide-search-field" placeholder="Search for Abstracts, Guidelines, Meetings" aria-label="Search">
  <input type="checkbox" name="search[sections][]" value="1074" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1065" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1096" data-parent-id="1065" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1093" data-parent-id="1065" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1133" data-parent-id="1065" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1099" data-parent-id="1065" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1136" data-parent-id="1065" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1077" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1310" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1071" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1053" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1062" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1100" data-parent-id="1062" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1087" data-parent-id="1062" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1106" data-parent-id="1062" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1090" data-parent-id="1062" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1059" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1056" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1047" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1080" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1109" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1050" data-parent-id="720" class="tag-input" hidden="hidden">
  <input type="checkbox" name="search[sections][]" value="1112" data-parent-id="720" class="tag-input" hidden="hidden">
  <div class="clear-toggle"><span class="clear-icon"></span></div>
  <button type="submit" class="search-submit btn btn-primary" title="Search"> Search </button>
  <div class="autocomplete-suggestions" style="position: absolute; display: none; width: 100%; max-height: 300px; z-index: 1;"></div>
</form>

Text Content

Oops, you're using an old version of your browser so some of the features on
this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer
11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23


 * ESMO
 * Meeting Calendar
 * OncologyPRO

Become a member
 * Login


Search

 1. ESMO
 2. Policy


WORLD HEALTH ORGANIZATION (WHO)



Search

 * ESMO
 * Meeting Calendar
 * OncologyPRO

 * About ESMO
   * ESMO Vision 2025
     * One Oncology Community
     * Education for Life
     * Accessible Cancer Care
   * ESMO Mission
   * ESMO Values
   * Awards
     * ESMO Award Nominations
     * Fellow of ESMO (FESMO)
       * FESMO 2023
       * FESMO 2022
     * ESMO Award
     * ESMO Award for Translational Research
     * ESMO Women for Oncology Award
     * ESMO Lifetime Achievement Award
     * ESMO Breast Cancer Award
     * Heine H. Hansen Award
     * ESMO Award for Immuno-Oncology
     * TAT Honorary Award
   * Organisational Structure
     * ESMO Council
     * Executive Board
     * Annals of Oncology Editorial Board
     * Audit Committee
     * Cancer Medicines Committee
     * Communication Committee
     * Compliance Committee
     * Educational Committee
       * Adolescents and Young Adults Working Group
       * Designated Centres Working Group
       * Educational Publications Working Group
       * ESMO Faculty
       * ESMO SIOG Cancer in the Elderly Working Group
       * Examination & Accreditation Working Group
       * OncologyPRO Working Group
       * Practising Oncologists Working Group
       * Real World Data and Digital Health Working Group
       * Translational Research and Precision Medicine Working Group
     * ESMO Faculty
     * ESMO Gastrointestinal Oncology Editorial Board
     * ESMO Industry Strategic Forum
     * ESMO Members: Get Involved
       * ESMO-MCBS Working Group - Open Call for New Members
       * Volunteer with ESMO
       * YOC Open Call for Members
     * ESMO Open Editorial Board
     * ESMO Real World Data and Digital Oncology Editorial Board
     * ESMO Task Forces
       * ESMO Gender Medicine Task Force
       * Climate Change Task Force
       * Resilience Task Force
       * ESMO Clinical Research Observatory Task Force (ECRO)
     * Guidelines Committee
       * ESMO-Magnitude of Clinical Benefit Scale Working Group
       * Major Achievements
     * IOTECH Editorial Board
     * Leadership Development Committee
     * Membership Committee
     * National Societies Committee
     * Nomination Committee
     * Women for Oncology Committee
     * Young Oncologists Committee
       * Major Achievements
   * How we work
     * Declaration of Interest
       * EFPIA Disclosure Code
     * ESMO Presidential Election: 2027-2028
       * ESMO Elections FAQ
     * ESMO Structure
     * Code of Conduct
     * ESMO Annual Report
     * ESMO Funding
       * 2019 Funding Sources
       * 2020 Funding Sources
       * 2021 Funding Sources
       * 2022 Funding Sources
       * 2023 Funding Sources
     * ESMO Bylaws
     * General Assembly
       * Notice of the 2024 Ordinary Annual General Assembly Vote
   * Biographies
   * Careers at ESMO
   * Discover ESMO Journals
     * Annals of Oncology
       * About Annals of Oncology
       * Annals of Oncology 35th Anniversary
     * ESMO Open
       * Frequently Asked Questions
     * Immuno-Oncology and Technology
     * ESMO Gastrointestinal Oncology
     * ESMO Real World Data and Digital Oncology
     * ESMO Affiliated Journals
       * Cancer Treatment Reviews
       * Clinical Lymphoma Myeloma and Leukemia
       * Lung Cancer
       * The Breast
     * ESMO Rare Cancers
     * COVID-19 and cancer care in the ESMO journals
   * ESMO Brand
     * ESMO Logo
   * Collaborate with ESMO
     * Frequently Asked Questions
   * President Letter
     * Stepping into the shoes of a Society with a global footprint
     * Embracing a year of strong collaboration and steady progress
   * Joining Forces
     * ESMO for World Cancer Day 2024
     * ESMO for World Cancer Day 2023
     * ESMO for World Cancer Day 2022
     * ESMO for World Cancer Day 2021
     * ESMO for World Cancer Day 2020
   * Contact Us
 * Membership
   * Join ESMO
   * Member Benefits
   * Membership Categories & Annual Fees
 * Guidelines
   * Guidelines by topic
     * Breast Cancer
     * Cancers of Unknown Primary Site
     * Endocrine and Neuroendocrine Cancers
     * Gastrointestinal Cancers
     * Genitourinary Cancers
     * Gynaecological Cancers
     * Haematological Malignancies
     * Head and Neck Cancers
     * Hereditary Syndromes
     * Lung and Chest Tumours
     * Melanoma and Skin Cancers
     * Neuro-Oncology
     * Sarcoma and GIST
     * Supportive and Palliative Care
   * Guidelines News
   * ESMO Expert Consensus Statements
   * Pan-Asian Guidelines Adaptation (PAGA)
   * ESMO Guidelines Methodology
   * Pocket Guidelines & Mobile App
     * Translated ESMO Pocket Guidelines
   * Guidelines Slide Sets
   * Cancer Patient Management During the COVID-19 Pandemic
     * Disclaimer
     * Primary brain tumours in the COVID-19 era
     * Gastrointestinal cancers: Hepatocellular carcinoma (HCC) in the COVID-19
       era
     * Genitourinary cancers: Urothelial cancer of the bladder in the COVID-19
       era
     * Genitourinary cancers: Renal cell cancer in the COVID-19 era
     * Genitourinary cancers: Prostate cancer in the COVID-19 era
     * Gynaecological malignancies: Cervical cancer in the COVID-19 era
     * Gynaecological malignancies: Endometrial cancer in the COVID-19 era
     * Haematological malignancies: DLBCL, MCL and Aggressive T-cell lymphoma in
       the second phase of the COVID-19 pandemic (ESMO-EHA)
     * Haematological malignancies: Hodgkin lymphoma in the second phase of the
       COVID-19 pandemic (ESMO-EHA)
     * Haematological malignancies: Indolent B-NHL in the second phase of the
       COVID-19 pandemic (ESMO-EHA)
     * Haematological malignancies: Multiple myeloma in the COVID-19 era
     * Head and neck cancers in the COVID-19 era
     * Melanoma in the COVID-19 era
     * Sarcomas in the COVID-19 era
     * Supportive Care in the COVID-19 era
   * COVID-19 Palliative Care Pathways
   * Q&A on COVID-19
   * COVID-19 adapted recommendations Slide Sets
   * ESMO-MCBS
     * ESMO-MCBS in Action
     * ESMO-MCBS sessions at ESMO 2020
     * ESMO-MCBS for Solid Tumours
     * ESMO-MCBS for Haematological Malignancies
     * ESMO-MCBS Online Tutorials
     * About the ESMO-MCBS
     * ESMO-MCBS Terms of Use
 * Meetings
   * Meeting Calendar
     * Past Meetings
   * ESMO Congresses
   * ESMO Virtual Plenaries
     * Sponsors
   * ESMO Academy
   * ESMO Advanced Courses
     * FAQs
     * Acknowledgements
     * Testimonials
   * ESMO Preceptorship Courses
     * Acknowledgements
     * FAQs
     * Testimonials
   * ESMO Summits
     * Testimonials
   * ESMO Courses in Medical Oncology for Medical Students
     * ESMO Best Student Award
     * Testimonials
   * ESO-ESMO Masterclasses
   * ESMO Symposia
   * ESMO Colloquia
   * ESMO Webinar Series
   * Workshops
   * ESMO Events App
     * How to Use the App
   * ESMO Licensed Events
 * Career Development
   * Oncology Fellowships
     * Host Institutes
     * Host an ESMO Fellow
     * Fellowship Offers
     * Benefits for Institutes
     * Awardees and Reports
     * External Oncology Fellowship Opportunities
     * About Oncology Fellowships
   * Resilience Task Force
     * ESMO Resilience Task Force: Survey Series
   * Young Oncologists Corner
     * Young Oncologists Track
     * YO4YO Virtual Session Series
     * About Young Oncologists Corner
     * National Activities
     * Considering a Career Abroad?
   * ESMO Examination
     * Parallel Sessions
     * Why Sit the ESMO Exam?
     * ESMO Exam Talent Pool
     * Sample Exam Questions Explained
     * Best Exam Award
   * Recertification & CME
     * ESMO-MORA Recertification Process and Requirements
     * CME Tests for Handbooks
   * ESMO Certificate of Professional Development
     * ESMO Advanced Courses
     * ESMO Preceptorship Courses
     * ESMO Virtual Plenaries
     * ESMO Webinar Series
   * Jobs in Oncology
   * Women for Oncology
     * ESMO W4O Observatory
     * W4O Hub
     * Resource Centre
     * W4O Sessions and Events
   * Leaders Generation Programme
     * Class of 2021-2022
     * Class of 2016
     * Class of 2017
     * Class of 2018
     * Class of 2019
   * Leaders Generation Programme Asia
     * Class of 2019
     * Class of 2022
   * Travel Grants for ESMO Meetings
   * About Career Development
 * Scales and Tools
   * ESMO Guidance for Reporting Oncology real-World Evidence (ESMO-GROW)
   * ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
   * ESMO-MCBS
 * Research
   * About the Grant Schemes
   * ESMO Clinical Research Observatory Task Force (ECRO)
     * Acknowledgements: Rationalizing Bureaucracy
     * Bibliography on Clinical Trial Procedures
   * Research Funding opportunities
     * ESMO Webinar: EU Research Opportunities
     * How to Apply For EU Grants
     * EU Calls for Proposals
     * Training and Events
     * Regulatory Information
     * Other Research Funding Opportunities
   * Research Groups, Tools and Database
     * General research groups
     * Cancer research groups by type
     * Databases
     * Research tools
   * COVID-19 and Cancer: Registries, Studies and Surveys
     * ESMO-CoCARE Registry
 * For Patients
   * Resources for Patients with Cancer
   * ESMO Designated Centres of Integrated Oncology and Palliative Care
     * Palliative and Supportive Care Sessions at ESMO Congress 2022 Paris
     * Designated Centres Working Group
     * Palliative and Supportive Care Sessions at ESMO Congress 2023 Madrid
     * 2024 ESMO Designated Centres
     * Palliative and Supportive Care Sessions at ESMO Congress 2024 Barcelona
   * Cancer Care During the COVID-19 Pandemic
     * Multiple Myeloma
     * Melanoma
     * Sarcoma
     * Krebstherapie während der COVID-19-Pandemie
     * Renal Cell Carcinoma
     * Prostate Cancer
     * Pancreatic Cancer
     * Lung Cancer
     * Ovarian Cancer
     * Supportive Care Glossary
     * Palliative Care Glossary
     * Gastro-Oesophageal Cancer
     * Hepatocellular Carcinoma
     * Endometrial Cancer
     * Colorectal Cancer
     * Primary Brain Tumour
     * Aggressive Lymphoma Management
     * Breast Cancer
     * B-cell non-Hodgkin Lymphoma
     * Urothelial Bladder Cancer
     * Hodgkin Lymphoma
     * Cervical Cancer
     * Traitement du Cancer au Cours de la Pandémie de COVID-19
     * Le Cure per il Cancro Durante la Pandemia da COVID-19
     * Cuidado del cáncer durante la pandemia de COVID-19
     * Glossary
   * Patient Advocates Working Group
     * Call for Applications
   * Patient Advocacy Track
   * Patient Guides
     * Patient Guides by Language
     * Bone Health in Cancer
     * Immunotherapy Side Effects
     * Survivorship
     * Cancer Pain Management
     * Personalised Cancer Medicine
   * Personalised Medicine Explained
   * Getting the Most out of Your Oncologist
   * ESMO Patient Engagement Summit
 * Policy
   * ESMO Manifesto
   * Policy News
   * Public Policy Committee
   * Patient Advocates Working Group
   * Cancer Medicines Committee
   * ESMO Public Policy Track and Special Sessions
 * Newsroom
   * Press and Media Hub
   * ESMO Daily Reporter
   * Oncology News
   * ESMO Society Updates

Become a member


 * Login


ESMO COLLABORATES WITH THE WORLD HEALTH ORGANIZATION (WHO) TO TACKLE THE GLOBAL
SCOURGE OF CANCER

ESMO has been supporting and promoting WHO’s global initiatives since 2002 and
was granted ‘Official Relations Status’ in 2013. As a result of this status,
ESMO can amplify its policy messaging through participation in WHO governing
body meetings and the delivery of official statements to all Member States.

Technical collaboration between WHO and ESMO is implemented through multiannual
work plans that focus on implementing resolutions on cancer, evaluation of
cancer medicines for the WHO List of Essential Medicines (EML), optimising
cancer workforce, and development and implementation of the WHO Integrated
Health Tool (IHT) module for cancer to scale up national cancer control plans.
ESMO has supported the expanding of the IHT with data from two cancers to 20
cancers, and by supporting its implementation so far in five countries
(Mozambique, Kenya, Kyrgyzstan, Senegal, Palestine).

Dr Raffaella Casolino is the third ESMO young medical oncologist on the World
Health Organization (WHO) Cancer Control team in Geneva. Since February 2023,
she is working as a WHO staff member to implement the current WHO-ESMO workplan
through several global cancer initiatives that aim to support countries in the
achievement of the goals of the 2017 World Health Assembly Cancer Resolution and
Universal Health Coverage. The position is made possible through ESMO’s status
as a Non-State Actor in official relations with the WHO and attendant work to
foster a dialogue between oncology and global health.    

Over the years, ESMO has supported the adoption of many WHO resolutions,
including on reducing premature deaths from cancer, improving access to cancer
services, medicines, and palliative care, achieving universal health coverage,
building up the oncology workforce, and ensuring continuity of cancer care
during health emergencies. In addition, ESMO has contributed to WHO global
initiatives for childhood, cervical, and breast cancer, with technical input and
references to the ESMO Clinical Practice Guidelines, including those on
fertility preservation and supportive and palliative care. A prominent example
of ESMO-WHO collaboration at the country level is a project with the Ministry of
Health of Kazakhstan, where ESMO reviewed the country's cancer treatment
standards, which supported the Ministry in optimising its cancer treatment
protocols.



LANDMARK DECISIONS AND REPORTS THAT ESMO ACTIVELY SUPPORTED ARE THE: 

 * 2023: Strengthening clinical trials to provide high-quality evidence on
   health interventions and to improve research quality and coordination
 * 2022: Human Resources for Health
 * 2022: Follow-up to the political declaration of the third high-level meeting
   of the General Assembly on the prevention and control of non-communicable
   diseases
 * 2022: The Public Health Dimension of the World Drug Problem
 * 2021: WHO Europe Resolution on the 'European Immunization Agenda 2030'
 * 2021: WHO Europe Resolution on 'Realizing the potential of primary health
   care: lessons learned from the COVID-19 pandemic and implications for future
   directions in the WHO European Region'
 * 2021: WHO Resolution on 'Strengthening WHO preparedness for and response to
   health emergencies'
 * 2021: WHO Resolution on 'Social determinants of health'
 * 2021: WHO Resolution on 'Protecting, safeguarding and investing in the health
   and care workforce'
 * 2021: WHO Decision on the 'Global Coordination Mechanism on noncommunicable
   diseases and expanding access to effective treatments for cancer and rare and
   orphan diseases'
 * 2020: WHO Resolution on COVID-19 Response. 
 * 2020: WHO Report on Cancer: Setting priorities, investing wisely and
   providing care for all
 * 2019: UN Political Declaration on Universal Health Coverage (UHC)
 * 2019: WHO Roadmap for access to medicines, vaccines and other health
   products, 2019-2023
 * 2018: UN Political Declaration on Non-communicable Diseases (NCDs)
 * 2018: WHO Report on Addressing the global shortage of, and access to,
   medicines and vaccines
 * 2017: WHO Resolution on Cancer Prevention and Control in the Context of an
   Integrated Approach
 * 2016: Outcome Document of the United Nations General Assembly Special Session
   on the World Drug Problem
 * 2014: WHO Resolution on Strengthening of palliative care as a component of
   comprehensive care throughout the life course

ESMO advocated for the inclusion in these documents of specific actions on
cancer, including the need to ensure a core set of cancer and palliative care
services in national universal health coverage benefit packages so that no
cancer patient is left behind. To assist countries in implementing the 2017 WHO
Cancer Resolution, ESMO is collaborating on WHO projects to optimize the cancer
workforce, scale up NCCPs, increase access to medicines, improve cancer
treatment and care for childhood and cervical cancer, and to promote cancer
prevention and healthy lifestyles, in addition to disseminating WHO’s global
policy recommendations on cancer prevention and control.

ESMO contributed to the review of the WHO Report on Cancer: Setting priorities,
investing wisely and providing care for all, which highlights one example of how
ESMO and WHO are working together for sustainable cancer care. The WHO report
cites a case study of a joint project with ESMO and the Ministry of Health of
Kazakhstan, where ESMO reviewed the  country's cancer treatment standards, using
the WHO Model List of Essential Medicines, the European Medicines Agency's
medicine indications, the ESMO Clinical Practice Guidelines,  the ESMO-Magnitude
of Clinical Benefit Scale version 1.1 and expert peer review. The assessment
supported the Ministry of Health in optimizing its cancer treatment protocols
and linking them to the national essential medicines list as well as maintaining
the country’s long-standing commitment to offer its citizens evidence-based
comprehensive cancer care as part of universal health coverage plan.

Find out more about ESMO’s participation in WHO meetings of the World Health
Assembly, and UN High-Level Meetings, and read ESMO’s official statements at
these meetings on critical issues related to cancer.


RELATED LINKS

 * United Nations High-Level Meetings
 * WHO Meetings
 * News ESMO Working with WHO to Improve Selection and Use of Essential Cancer
   Medicines
 * News ESMO Congratulates the World Health Organization on its 75th
   Anniversary 
 * News ESMO urges WHO Member States to place cancer prevention and care at the
   core of decision-making on health systems




LEGAL

 * Terms of Use
 * Privacy Policy

Change cookie settings

USEFUL LINKS

 * About ESMO
 * Contact Us

SUBSCRIBE TO ESMO NEWSLETTERS

Login to your ESMO account to sign up for ESMO newsletters and receive
information about ESMO's scientific and educational resources, events, member
benefits.



ESMO is a Swiss-registered not-for-profit organisation. All funding for this
site is provided directly by ESMO. Via Ginevra 4, 6900 Lugano - CH
© Copyright 2024 European Society for Medical Oncology All rights reserved
worldwide.

 * Twitter
 * Facebook
 * Youtube
 * RSS
 * LinkedIn
 * Instagram

MEMBERSHIP VALUE SURVEY

Your opinion is important. 

Take the Membership Value Survey today ×


This site uses cookies. Some of these cookies are essential, while others help
us improve your experience by providing insights into how the site is being
used.

For more detailed information on the cookies we use, please check our Privacy
Policy.

Customise settings
Reject all cookies Accept all cookies
 * Necessary cookies
   
   Necessary cookies enable core functionality. The website cannot function
   properly without these cookies, and you can only disable them by changing
   your browser preferences.

 * Analytics cookies
   
   Analytics cookies help us improve our website by collecting and reporting
   information on its usage.

 * Marketing cookies
   
   We use marketing cookies to build a profile of you as a user through your
   actions on our site in order to better understand your interests and provide
   you with pertinent suggestions.

Save selected settings